XML 66 R17.htm IDEA: XBRL DOCUMENT v3.2.0.727
STOCKHOLDERS' EQUITY
12 Months Ended
Jun. 30, 2015
Stockholders Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
NOTE 10– STOCKHOLDERS’ EQUITY
 
Common Stock
 
On September 26, 2013, the Company issued 118,778 shares of Common Stock at the market price of $4.42 per share to Mr. Tao Li as repayment for $ 200,000 he previously advanced the Company and $325,000 for unpaid compensation.
 
On September 28, 2013, the Company granted an aggregate of 1,750,000 shares of restricted stock under the 2009 Plan to certain executive officers, directors and employees. among which (i) 480,000 shares of restricted stock to Mr. Tao Li, the CEO; (ii) 200,000 shares of restricted stock to Mr. Ken Ren, the CFO, (iii) 40,000 shares of restricted stock to Mr. Yizhao Zhang, 30,000 shares of restricted stock to Ms. Yiru Shi, and 20,000 shares of restricted stock to Mr. Lianfu Liu, each an independent director of the Company; and (iv) 980,000 shares of restricted stock to 220 employees. The stock grants are subject to time-based vesting schedules, vesting in various installments until March 31, 2014 for the CFO and the three independent directors, until March 31, 2015 for the CEO and until December 31, 2015 for the employees.
 
During the year ended June 30, 2014, the Company issued 17,356 shares of common stock for consulting services valued at $65,535. The shares were valued at the market price on the date of issuance. On July 28, 2014, the Company issued 4,087 shares to its consultant for its consulting services valued at $12,950, and 19,665 shares of common stock to its counsel for the legal services valued at $41,494.13.
 
On September 30, 2014, the Company granted an aggregate of 1,750,000 shares of restricted stock under the 2009 Plan to certain executive officers, directors and employees, among which (i) 240,000 shares of restricted stock to Mr. Tao Li, the CEO; (ii) 100,000 shares of restricted stock to Mr. Ken Ren, the CFO, (iii) 40,000 shares of restricted stock to Mr. Yizhao Zhang, 30,000 shares of restricted stock to Ms. Yiru Shi, and 20,000 shares of restricted stock to Mr. Lianfu Liu, each an independent director of the Company; and (iv) 1,320,000 shares of restricted stock to key employees. The stock grants are subject to time-based vesting schedules, vesting in various installments until March 31, 2015 for the CFO and the three independent directors, until June 30, 2015 for the CEO and until December 31, 2016 for the employees. The value of the restricted stock awards was $3,675,000 and is based on the fair value of the Company’s common stock on the grant date. This amount is being amortized to compensation expense over the vesting periods for the various awards. 
The table below summarized the restricted shares of common stock issued under the 2009 Plan:
 
 
 
 
 
 
 
Grant Date
 
 
 
Number of
 
Fair Value of
 
Fair Value
 
 
 
Shares
 
Shares
 
Per share
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding (unvested) at June 30, 2012
 
 
721,151
 
$
1,637,133
 
 
 
 
Granted
 
 
1,750,000
 
 
5,132,500
 
$
2.93
 
Forfeited
 
 
0
 
 
0
 
 
 
 
Vested
 
 
(818,651)
 
 
(3,100,685)
 
 
 
 
Outstanding (unvested) at June 30, 2013
 
 
1,652,500
 
 
3,668,948
 
 
 
 
Granted
 
 
1,750,000
 
 
7,490,000
 
$
4.28
 
Forfeited
 
 
0
 
 
0
 
 
 
 
Vested
 
 
(1,688,500)
 
 
(8,054,189)
 
 
 
 
Outstanding (unvested) at June 30, 2014
 
 
1,714,000
 
 
3,104,759
 
 
 
 
Granted
 
 
1,750,000
 
 
3,675,000
 
$
2.10
 
Forfeited
 
 
0
 
 
0
 
 
 
 
Vested
 
 
(1,756,000)
 
 
(4,981,767)
 
 
 
 
Outstanding (unvested) at June 30, 2015
 
 
1,708,000
 
$
1,797,992
 
 
 
 
 
As of June 30, 2015, the unamortized expense related to the grant of restricted shares of common stock was $1,797,992 which will be amortized into expense through December 31, 2016. The fair value of the restricted common stock awards was based on the closing price of the Company’s common stock on the grant date. The fair value of the common stock awarded is amortized over the various vesting terms of each grant.
 
During the year ended June 30, 2014, the Company issued 17,356 shares of common stock for consulting services valued at $65,535. During the year June 30, 2015, the Company issued 103,686 shares of common stock for professional fees valued at $205,103. The shares were valued at the market price on the date of issuance.
 
In addition, during the year ended June 30, 2015, the Company issued 1,362,495 shares of common stock to its employees under the Company’s Employee Stock Purchase Plan (the “ESPP”) for cash of $2,946,746 and the Company sold 326,483 shares of common stock to its Chairman, Mr. Li, for cash proceeds of $626,847 under the ESPP.
 
Dividend
 
On October 1, 2014, the Company's Board of Directors declared a cash dividend of $0.10 per share to the Company's stockholders of common stock. The dividend payable represents a total payment to the stockholders of $3,296,156. The cash dividend of $2,161,904 was paid on January 30, 2015 to stockholders of record as of the close of business on the record date of October 31, 2014. Certain stockholders, including the Company’s Chairman, Mr. Li, elected to waive the dividend payment due to them and directed the Company to retain the funds for working capital purposes. 
 
Preferred Stock
 
Under the Company’s Articles of Incorporation, the Board has the authority, without further action by stockholders, to designate up to 20,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, privileges, qualifications and restrictions granted to or imposed upon the preferred stock, including dividend rights, conversion rights, voting rights, rights and terms of redemption, liquidation preference and sinking fund terms, any or all of which may be greater than the rights of the common stock. If the Company sells preferred stock, it will fix the rights, preferences, privileges, qualifications and restrictions of the preferred stock of each series in the certificate of designation relating to that series and will file the certificate of designation that describes the terms of the series of preferred stock the Company offers before the issuance of the related series of preferred stock.
 
As of June 30, 2015, the Company had 20,000,000 shares of preferred stock authorized, with a par value of $.001 per share, of which no shares are issued or outstanding.